The European APL Network are a collaborative group of academic and clinical key opinion leaders, who have substantially contributed to APL research and development of highly effective treatment stratagems over the past 30 years. The European APL Network complement their research efforts by directly sharing advice on best practice for healthcare professionals, guidance for patients and their personal advocates and also for patient advocacy groups, through this European APL Network – a charitable enterprise, and the voice of the European APL Network.

(i) This project is supported by Teva Pharmaceuticals Europe B.V.
(ii) Teva Pharmaceuticals Europe B.V. has no editorial control over the contents of this website.
(iii) This website and all the contents have been reviewed independently by the European APL Expert Group.